Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CBP 1008

Next Previous
Drug Profile

CBP 1008

Alternative Names: CBP-1008

Latest Information Update: 02 Jan 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Coherent Biopharma (Suzhou)
  • Class Antineoplastics; Drug conjugates; Immunoconjugates
  • Mechanism of Action Apoptosis stimulants; Mitosis inhibitors; Tubulin inhibitors; Tubulin polymerisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II/III Ovarian cancer; Triple negative breast cancer
  • Phase I/II Solid tumours

Most Recent Events

  • 13 Sep 2024 Updated adverse events and efficacy data from a phase Ia/Ib trial in Solid tumors presented at the 49th European Society for Medical Oncology Congress (ESMO-2024)
  • 30 Aug 2024 Phase-II/III clinical trials in Ovarian cancer (Monotherapy) in China (IV) (Coherent Biopharma pipeline, August 2024)
  • 30 Aug 2024 Phase-II/III clinical trials in Triple-negative-breast-cancer (Monotherapy) in China (IV) (Coherent Biopharma pipeline, August 2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top